A Phase 4, 6-Month Open-Label Extension Study to Evaluate the Safety, Tolerability, and Efficacy of Quillichew (Methylphenidate Hydrochloride (HCl) Extended Release Chewable Tablets (ERCT) in Children with Attention Deficit Hyperactivity Disorder
Administered By
Contributors
- Dew, Rachel E Principal Investigator
Start/End
- May 31, 2018 - January 16, 2019